Visral

Visral5 mg/2 ml

IM/IV Injection

Tiemonium Methylsulphate

Opsonin Pharma Ltd.

Product Code : 18175
MRP 27.00
5% Off
Best PriceTk
/
1
Section

Alternatives

See All
Section

Medicine overview

Indications of Visral 5 mg/2 ml

Visral 5 mg/2 ml is an antispasmodic drug that reduces muscles spasm of the intestine, biliary system, bladder and uterus. It is used in symptomatic treatment of pain related to functional disorders of the digestive tract and biliary system. It is also indicated for the treatment of spasm and pain in urological and gynaecological diseases.

Theropeutic Class

Anticholinergics

Pharmacology

Visral 5 mg/2 ml a competitive antagonist of Acetylcholine, Histamine and strengthens of calcium bond with membrane phospholipids and proteins. Thus inhibits intracellular contractile protein of visceral cell which causes inhibition of visceral spasm and pain.

Dosage & Administration of Visral 5 mg/2 ml

Tablet/Syrup- Adult: usual dose is 2-6 tablets or 3-9 teaspoonfuls syrup daily in divided doses. Children: 3 ml/kg or 6 mg/kg body weight daily in divided doses. Injection: 1 Visral 5 mg/2 ml Injection 3 times daily, through Intravenous route slowly or Intramuscular route.Suppository: 20 mg Visral 5 mg/2 ml suppository two or three times daily, through rectal route.

Dosage of Visral 5 mg/2 ml

Tablet/Syrup- Adult: usual dose is 2-6 tablets or 3-9 teaspoonfuls syrup daily in divided doses. Children: 3 ml/kg or 6 mg/kg body weight daily in divided doses. Injection: 1 Visral 5 mg/2 ml Injection 3 times daily, through Intravenous route slowly or Intramuscular route.Suppository: 20 mg Visral 5 mg/2 ml suppository two or three times daily, through rectal route.

Interaction of Visral 5 mg/2 ml

Tiemonium methylsulphate tablet should not be used with other drugs without prior consult of a registered physician to avoid possible drug interaction.

Contraindications

It should not be used in urethroprostatic disorder involving a risk of urine retension. It is contraindicated in patient with having risk of angle closure glaucoma.

Side Effects of Visral 5 mg/2 ml

Visral 5 mg/2 ml may have the risk of hypotension & tachycardia in certain individuals.

Pregnancy & Lactation

The results of animal studies of Visral 5 mg/2 ml did not reveal any teratogenic effects; no deformities have been reported up till now with normal use. In absence of sufficient data, prudence should be the rule for nursing mothers although no problems have been reported with normal use.

Precautions & Warnings

Caution should be taken during treatment of patients with disorders of the prostate. Caution should also be taken in case of chronic bronchitis, coronary insufficiency, ambient hyperthermia, renal & hepatic insufficiency. The risks of visual disturbances can make it dangerous to drive or use machines.

Overdose Effects of Visral 5 mg/2 ml

There is not available data regarding the overdose of Tiemonium methylsulphate tablet.

Storage Conditions

Keep in a dry place, away from light and heat. Keep out of the reach of children.

Use In Special Populations

Paediatric use: safety and effectiveness of Tiemonium methylsulphate in paediatric patients have not been established.Geriatric use: Efficacy and safety were maintained with increasing age.

Drug Classes

Anticholinergics

Mode Of Action

Visral 5 mg/2 ml a competitive antagonist of Acetylcholine, Histamine and strengthens of calcium bond with membrane phospholipids and proteins. Thus inhibits intracellular contractile protein of visceral cell which causes inhibition of visceral spasm and pain.

Pregnancy

The results of animal studies of Visral 5 mg/2 ml did not reveal any teratogenic effects; no deformities have been reported up till now with normal use. In absence of sufficient data, prudence should be the rule for nursing mothers although no problems have been reported with normal use.

Pediatric Uses

Paediatric use: safety and effectiveness of Tiemonium methylsulphate in paediatric patients have not been established.Geriatric use: Efficacy and safety were maintained with increasing age.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.